Geopolitical unrest clouds the outlook

The margin squeeze continued at Yara and remained stronger than anticipated by analysts (consensus – sales: -12.6%; EBITDA -37.0%; net income: -99%). Sales prices had fallen more strongly, not being offset by lower energy prices. The margin deterioration remained strong. The underlying agro fundamentals look positive, but the current geopolitical situation might weigh on the order pattern in Q4.

Strong margin squeeze in Q2

Yara’s profitability was between a rock and a hard place in the Q2. A significant fall in sales prices smashed profitability, which was not fully offset by lower energy prices. Volumes showed some recovery. This scenario had been broadly anticipated although its magnitude was far greater (miss to consensus -sales: -13.5%; Yara’s EBITDA: -56.9%; net result: loss of USD-298m vs: USD185m consensus estimate). The management indicated that the worst could be over. Curtailments have been lowered and

Lower prices make a dent in profitability

After skyrocketing profitability, Yara had to deal with a perfect set of opposite effects heavily weighing on profitability: sharply falling commodity prices, still curtailed production and inventory values based on high energy costs. Nevertheless, consensus was not met at many levels (revenues: -11.4%; adjusted EBITDA: -43.0%; operating income: -67.1%), which might not amuse investors. The Q2 could be somewhat better as the management flagged higher demand in Europe and lower natural gas cost

Greater profitability allows for better shareholder return

Yara’s Q4 figures were a mixed bag with the top line missing street expectations (-1.6%), but clearly beating consensus when it comes to adjusted EBITDA (+8.0%). The main drivers were higher prices due to the skyrocketing energy prices. On the other hand, high fertiliser prices have held back demand. The company will benefit from lower gas costs, which might be at the Q4 21 levels (pre-Ukraine-war levels), which should put pressure on sales prices, but not necessarily on margins.

Strong margins in a curtailed environment

Yara’s production volumes and deliveries suffered from the curtailed European production, but the extraordinary market situation still allowed for good margins albeit not extraordinary. The situation in the gas markets seems to have peaked as the company guidance is for lower, but still extremely high spot prices. Yara’s Q3 figures were a consensus-beating surprise (sales: +17.5%; adjusted EBITDA: +37.6%). Another positive catalyst is the lower-than- previously-anticipated gas costs (USD540m v

Still ahead of the cost curve

Yara reported consensus-beating Q2 sales (beat to consensus: +1.7%) and profitability figures (operating income: +9.5%). The strong profitability increase was mainly fostered by the higher sales prices as production volumes suffered from lower ammonia production. Once again, management guided for higher gas prices, based on the crucial assumption of if it is available, especially in Europe. Reported figures broadly confirmed our view on the company, but it is a bet on quite normal gas flows in

Positive sale price delta

Yara’s very profitable start came on the back of significant price increases, whereas sales volumes were subdued due to farmers’ reluctance to buy expensive fertilizer. The situation might have eased had Gazprom not announced that it was stopping gas transport to some European countries. This might additionally tighten the European nitrogen market helping Yara to cope with higher gas costs. The reported figures slightly missed consensus expectations for the top line (-1.2%), whereas operating

Turning the tide?

Yara’s FY figures were strong, but EBITDA followed the top line more distantly than expected (miss to consensus top line: -2.4%; EBITDA: -11%). EBITDA’s +26% increase was held back by skyrocketing gas prices as well as by higher impairments. On a quarterly adjusted basis, the picture looks more favourable as higher sales prices outweighed the extremely high energy costs in Q4. In our view, 2022 will be quite a profitable year despite the to-be-expected declining gas prices, if the Russia-Ukrai

Balancing lower ammonia production and high gas prices

Yara did better than the street had expected (top line: +5.1%; EBITDA: +2.5%), but that was the past. Central questions in today’s call were around the impact of the currently ongoing curtailment of its European production capacities and farmers’ willingness to accept continuously increasing prices. Management remained quite vague in this regard due to its conservatism, but clearly flagged that nitrogen is crucial for farmers to produce certain yields.

Food prices become a concern as gas prices soar

Yara and CF Industries, two leading ammonia producers, have announced they are to curtail quite a high share of their European production. This comes after the soaring gas prices, which can not be passed on to the farmers. The lower European production comes with the impact of Hurricane Ida. The heavy winds had caused severe damage and sudden shutdowns in the Mexican Gulf region, so the global supply balance has been hit. It looks to us as if this is becoming another perfect storm.

Strongly driven by higher prices

Yara reported a strong set of figures primarily driven by the implemented higher sales prices beating our cautious expectations, whereas consensus was more moderately beaten (top-line: 6; profitability: +2). In our view, the price increases overcompensated for the higher energy costs and weighed on volumes. However, the times of increasing prices is not over as management guides for higher forward prices until the year-end.

Energy prices start to be the expected pain

The world lusts for nitrogen-containing fertilisers as availability dominates pricing negotiations with ammonia prices flying up since the beginning of Q1. Being part of the story, Yara was one of the beneficiaries despite volume’s tiny performance. The higher sales prices could be introduced also because of the sharp (!) increase in natural gas prices yoy and sequentially. Our not too ambitious expectations were beaten, especially on the profitability level, but consensus was missed on all line

Going for green ammonia

Yara reported a good set of figures, beating our more moderate view in 2020 as we has factored in a stronger negative from higher energy prices. The latter has been counteracted by higher volumes and better pricing momentum in Q4. In the light of the fading effect from low energy prices, the provided outlook and already signed contracts will help profitability to be maintained in the first months of 2021, at a minimum. Consensus was not met.

Energy prices and FX headwind

Yara will release its Q4 results on 9 February, and we expect an EBITDA (Yara definition) of USD 495m (499). We have implemented firmer European gas prices and updated FX assumptions, representing headwind for earnings. This has been partly offset by higher price assumptions. Following our estimate revisions, we see limited scope for raising our NOK TP, and we hence downgrade the stock to Hold (Buy).

Headlines from ESG investor seminar

Targets new USD 300-600m EBITDA by 2025 2020-21 CapEx unchanged, 2022 higher than expected Unchanged financial targets Plans for 500’t green ammonia plant in Norway

Renold - Strong end to FY24: EPS up 11%. Robust FY25: EPS up 27.6%

The FY24 year-end update is very upbeat signalling trading being materially ahead of expectations, with a better-than-expected profit out turn and stronger cash generation. It continues to strengthen margins through efficiencies and investment in modern equipment. The order book remains close to record levels providing a robust view of future forecasts. In FY24E we upgrade EPS by 11% and in FY25E a significant upgrade of 27.6%. It looks capable of declaring a dividend in FY25 as well as manageme

Morning Note – 16 April 2024

Billington Holdings - Record result boosts dividend; forecasts upgraded

FY23 results show very strong growth over FY22, driven by strong Structural Steel activity, with results slightly ahead of upgraded profit expectations, while stronger than expected cash flow resulted in an unexpectedly generous dividend of 33p (offering a FY23 yield of 7.0%). The group now has net cash of £22.1m and is debt free and is therefore in a strong position for potential M&A activity. Following the recent £90m of new orders to increase the order book to record levels we conservatively

Q1 Operating Results

Another Good Year of Diversified Growth with More to Come in 2024 CCapital have released their Q1 operating results. Overall, revenue has come in slightly lower than expected at $80.2m vs TamE of $85.9m but is largely tracking in line with our FY24 annual estimate and we note the company has maintained guidance. Drilling revenue for this quarter was impacted by a fall in utilisaztion rates as well as general remobilisation geographically but we expect a strong recovery throughout the year as k

Plant Health Care - China distribution with AMVAC

Plant Health Care announced it has signed a distribution agreement with AMVAC, an American Vanguard Company, to support commercialisation of novel fertiliser products incorporating Plant Health Care's Harpinαβ in China starting in 2024. The novel product combines Harpinαβ technology with an AMVAC fertiliser and is expected to help growers improve crop quality and yield as part of an integrated and environmentally responsible crop production programme. AMVAC continues to evaluate Plant Health Car

Morning Note – 15 April 2024

discoverIE - Back to organic growth

discoverIE’s March year-end update confirms a strong operational performance in challenging markets. Following two years when sales increased by +48%, FY 2024 Group sales were +1% ahead of 2023 at CER (reported -3%) driven by a +2% contribution from acquisitions and organic -1%. As expected, organic growth returned in the later part of the year (Q4 +2%, +11% sequentially) and the order book has reverted to normalised levels of c.4.5 months’ sales, which – combined with a continuing strong pipeli

Severfield - Multiple positives should excite investors

Severfield’s trading update indicates that FY23 results are expected to slightly exceed market expectations and the company ends the year with a record UK and Europe order book. Furthermore, with a positive trading outlook and net debt coming in lower than expected, Severfield has announced a £10m share buyback, highlighting the cash-generative nature of the company and management’s confidence in its position. The stock trades on an FY25 P/E of less than 6x and yields 7%, which we believe appear

Warns on brine supply costs

SP Angel . Morning View . Copper prices hold higher as China processing fees fall below $0/t amid low feedstock availability

PROGRESSIVE: Severfield: Targeted acquisition strategy aids growth path

Acquisitions have been an important element of Severfield management’s growth strategy, with the aim of adding new products, sectors and regions to what we have identified as exciting long-term organic opportunities. In this Spotlight report, we focus on the group’s targeted M&A approach, highlighting three significant deals.

LIBERUM: Severfield: Erratum: Better EPS and cashflow, and buyback

Hardman & Co Insight: 2023 was an annus horribilis for Quoted UK Infrastructure and Renewable Energy

The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no

Invinity Energy Systems - Update on Strategic Investment

Invinity’s update on discussions with strategic investors reveals interest from multiple parties. While this has slightly delayed finalising an agreement it increases the potential for a better outcome. Although details are unknown at this stage, we think there is enough in the statement to be comfortable that any agreements will be consistent with the company’s strategy of growing market share in core markets and using a licencing and royalty model in other markets.

Clean and competitive fertiliser